Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive ...
Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards ...
PHG secures FDA nod for AI-powered EchoNavigator R5.0, boosts its push into minimally invasive heart repair and expands U.S. market reach.
March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with ...
Philips’ DeviceGuide uses AI to track and visualise mitral valve replacement devices during mitral regurgitation procedures.
IntraSight Plus merges Philips’ technologies, offering co-registration, iFR/FFR physiology, and real-time device ...
Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide.
March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips' platform-b ...
Philips (NYSE:PHG) today announced the launch of its IntraSight Plus interventional guidance platform in the U.S. and Europe.
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools ...
Philips has secured an FDA clearance for its artificial intelligence program that tracks and guides the placement of a ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with ...